It is long recognized that cancer cells display increased glucose uptake and metabolism. In
a rate-limiting step for glucose metabolism, the glucose transporter (GLUT) proteins facilitate …

Prostate cancer (PCa) is heterogeneous, harboring phenotypically diverse cancer cell types.
PCa cell heterogeneity is caused by genomic instability that leads to the clonal competition …

Background Glucose transporter 1 (GLUT1) plays a critical role in tumorigenesis and tumor
progression in multiple cancer types. However, the specific function and clinical significance …

Castration-resistant prostate cancer (CRPC) displays a higher 18 F-FDG PET SUV max than
hormone-sensitive prostate cancer, which suggests a greater need for glucose metabolism …

Positron emission tomography/computed tomography (PET/CT) is widely used in prostate
cancer to evaluate the localized tumor burden and detect symptomatic metastatic lesions …

Although the incidence of de novo neuroendocrine prostate cancer (PC) is rare, recent data
suggest that low expression of prostate-specific membrane antigen (PSMA) is associated …

Amyloodinium ocellatum (AO) infection in silver pomfret (Pampus argenteus) causes
extensive mortality. Insufficient information exists on the molecular immune response of …

The mechanisms behind the Warburg effect in mammalian cells, as well as for the similar
Crabtree effect in the yeast Saccharomyces cerevisiae, are still a matter of debate: why do …

Glucose, chief metabolic support for cancer cell survival and growth, is mainly imported into
cells by facilitated glucose transporters (GLUTs). The increase in glucose uptake along with …

One of the hallmarks of cancer cells is the increased ability to acquire nutrients, particularly
glucose and glutamine. Proliferating cells need precursors for cell growth and NADPH …